Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walkme Ltd (NQ: WKME )

7.600 -0.190 (-2.44%)
Streaming Delayed Price Updated: 11:05 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Walkme Ltd

< Previous 1 2 3 Next >
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
What 8 Analyst Ratings Have To Say About WalkMe
Via Benzinga
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
BMO Capital Maintains Market Perform Rating for WalkMe: Here's What You Need To Know
Via Benzinga
WalkMe: Q3 Earnings Insights
Via Benzinga
Where WalkMe Stands With Analysts
Via Benzinga
Expert Ratings for WalkMe
Via Benzinga
Why WalkMe Stock Was Blasting Higher This Week
The company's latest quarter wasn't all that impressive, but it's expecting continued double-digit revenue growth. 
Via The Motley Fool
WalkMe: Q1 Earnings Insights
Via Benzinga
WalkMe's Earnings: A Preview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
Via Benzinga
Warner Bros. Discovery To Rally Around 62%? Here Are 10 Other Analyst Forecasts For Monday
Wells Fargo raised the price target for Stanley Black & Decker, Inc. (NYSE: SWK) from $85 to $90. Wells Fargo analyst Joe O'Dea maintained an Equal-Weight rating. Stanley Black & Decker shares rose 3%... 
Via Benzinga
WalkMe's Second Downsizing Of 2023: Analyst Expects Improved Operating Margins, Long-Term Growth
Needham analyst Scott Berg reiterates WalkMe Ltd (NASDAQ: WKME) with a Buy  
Via Benzinga
Expert Ratings for WalkMe
Via Benzinga
Analyst Ratings for WalkMe
Via Benzinga
5 Analysts Have This to Say About WalkMe
Via Benzinga
WalkMe's Focus On Enterprise Customer Will Drive Profitability, Analyst Says
Via Benzinga
Expert Ratings for WalkMe
Via Benzinga
Analyst Ratings for WalkMe
Via Benzinga
Where WalkMe Stands With Analysts
  Analysts have provided the following ratings for WalkMe (NASDAQ:WKME) within the last quarter: 
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Needham Is 'More Optimistic' on WalkMe's Value Proposition After Q1 Performance - Read Why
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
Earnings Scheduled For November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
Via Benzinga
Disney, Inotiv, Warby Parker And Some Other Big Stocks Moving Higher On Thursday
  Absci Corporation (NASDAQ: ABSI) jumped 38.8% to $5.83 after the company reported a narrower Q2 loss. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 283 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 236 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
Via Benzinga
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis. 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.